Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colorectal cancer vaccines

C A Maxwell-Armstrong1, L G Durrant, J H Scholefield

  • 1Department of Surgery, University of Nottingham, UK.

The British Journal of Surgery
|March 21, 1998
PubMed
Summary

Colorectal cancer vaccines are being developed to target specific antigens, stimulating immune responses. Research is ongoing, with several approaches in clinical trials for this experimental cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Have changes in colorectal surgery training impacted on mortality in cancer patients? A retrospective cohort study of 51,562 procedures.

Annals of the Royal College of Surgeons of England·2024
Same author

The ACPGBI recommends pause for reflection on transanal total mesorectal excision.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
Same author

Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus.

Scientific reports·2020
Same author

Post-translational modifications such as citrullination are excellent targets for cancer therapy.

Seminars in immunology·2020
Same author

The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018
Same author

Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus-Reducing the Colostomy Rate.

Journal of gastrointestinal cancer·2016

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Molecular pathology has identified key colorectal cancer antigens like 17-1A, 791Tgp72, and carcinoembryonic antigen.
  • Vaccines are being developed to harness the immune system against these identified cancer antigens.

Purpose of the Study:

  • To review current research and advancements in the field of colorectal cancer vaccines.
  • To inform healthcare professionals about experimental immunotherapeutic strategies for colorectal cancer.

Main Methods:

  • Literature search conducted using Medline and Bath Information Data System for colorectal cancer vaccines.
  • Evaluation of various vaccine approaches currently in Phase I, II, and III clinical trials.

Main Results:

  • Multiple vaccine strategies are under investigation, including anti-idiotypic antibody immunization, DNA vaccines, mucin-based vaccines, heat shock protein-based vaccines, oncogene vaccines, and viral vector vaccines.
  • These diverse approaches aim to elicit immune responses against colorectal cancer.

Conclusions:

  • Accumulating evidence suggests the potential for generating immune responses against colorectal cancer through vaccination.
  • While still experimental, these advancements in cancer vaccines warrant awareness among medical professionals, particularly surgeons.

Related Experiment Videos